Giulio Tarro graduated from Medicine School, Naples University (1962), Italy. Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus (2006). Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President, Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Virology, Oncology, Immunology and Microbiology
Ananda M. Chakrabarty -Ph.D. is a Bengali American microbiologist, scientist, and researcher, most notable for his work in directed evolution and his role in developing a genetically engineered organism using plasmid transfer while working at GE. Prof. Chakrabarty genetically engineered a new species of Pseudomonas bacteria (”the oil-eating bacteria”) in 1971 while working for the Research & Development Centre at General Electric Company in Schenectady, New York. At the time, four known species of oil-metabolizing bacteria were known to exist, Prof. Chakrabarty discovered a method for genetic cross-linking that fixed all four plasmid genes in place and produced a new, stable, bacteria species (now called pseudomonas putida) capable of consuming oil one or two orders of magnitude faster than the previous four strains of oil-eating microbes. The new microbe, which Chakrabarty called “multi-plasmid hydrocarbon-degrading Pseudomonas,” could digest about two-thirds of the hydrocarbons that would be found in a typical oil spill. The bacteria drew international attention when he applied for a patent—the first-ever patent for living organism. He was initially denied the patent by the Patent Office because it was thought that the patent code precluded patents on living organisms. Prof. Chakrabarty’s landmark research has since paved the way for many patents on genetically modified micro-organisms and other life forms and catapulted him into the international spotlight. Currently, his lab is working on elucidating the role of bacterial cupredoxins and cytochromes in cancer regression and arresting cell cycle progression. He has isolated a bacterial protein, azurin, with potential antineoplastic properties. He has expanded his lab’s work to include multiple microbiological species, including Neisseria, Plasmodia, and Acidithiobacillus ferrooxidans. In 2001, Prof. Chakrabarty founded a company, CDG Therapeutics, (incorporated in Delaware) which holds proprietary information related to five patents generated by his work at the University of Illinois at Chicago. Chakrabarty is currently a Distinguished University Professor in the Department of Microbiology and Immunology in the University of Illinois at Chicago College of Medicine. Apart from being an eminent scientist, Ananda Chakrabarty has been an advisor to judges, governments, and the UN. As one of the founding members of a UNIDO Committee that proposed the establishment of the International Centre for Genetic Engineering & Biotechnology (ICGEB), he has been a member of its Council of Scientific Advisors ever since. He has also served the Stockholm Environment Institute of Sweden. He has been on the Scientific Advisory Board of many academic institutions such as the Michigan Biotechnology Institute, the Montana State University Centre for Biofilm Engineering, the Centre for Microbial Ecology at the Michigan State University, and the Canadian Bacterial Diseases Network based in Calgary, Canada. Dr. Chakrabarty has also served as a member of NIAG, the NATO Industrial Advisory Group based in Brussels, Belgium. He is a member of the Board of Directors of Einstein Institute for Science, Health and the Courts, where he participates in judicial education. More recently, he has been involved in international judicial work, serving as a Scientific Advisor for meetings in Hawaii and Ottawa, Canada, organized by the Supreme Court of Canada. For his work in genetic engineering technology, he was awarded the civilian Padma Shri by the Government of India in 2007.
Dr.Taha has more than twenty (20) years of professional, research and academic experience in the field of clinical and applied pharmacy including drug screening and disease transmission models.He is also specialist in clinical microbiology; infectious diseases; molecular basis of antimicrobial resistance development and resistance patterns and also has a experience in Biosafety level 2 and 3 biological samples and performed biological and biochemical analyses including quantitative PCR analysis, chromatographic and spectroscopic based assays. Dr.Taha have strong background in data acquisition, writing, editing, reviewing and conceiving literatures related to clinical microbiology, pharmacology and clinical pharmacy at graduation and post-graduation level with excellent team player spirit and good leadership qualities
Professor.Dr.Ahmed G.Hegazi currently working as a professor of Microbiology and Immunology in National Research Center, Dokki, Giza, Egypt with a work experience of more than forty years. He bagged many awards and the recent one was “Merit Aware of Medical Sciences, 2016” and he has four patents, 224 Articles. He was Secretary General at African Federation of Apiculture Associations (AFAA) and member of many scientific boards and Editorial Board of many journals. His contributions to the field of Microbiology and Immunology was incredible and we are privileged to have him as Organizing member.
Microbiology & Immunology
Tummalapalli Venkateswara Rao is Doctorate in Medicine has expertise in teaching, Medicine, Microbiology and Infectious diseases in Medical schools and Medical Universities in India and abroad is an emeritus professor and former HOD, Department of Microbiology in Travancore Medical College, Kerala, India. Associated with Infectious Diseases division with Mansa General Hospitals Mansa Zambia ( 1978 to 1981) academic work included Schistosomiasis and Malaria He completed his MBBS in the year of 1973, from J N Medical College Belgaum India post graduate diploma in management of cerebral palsy at the spastic society of India, Bombay, and MD (Microbiology) from Andhra Medical college Visakhapatnam India In the recent past from 2007 on-wards taken the initiative to digitalize many of the issues/ complex problems related to Microbiology and Infectious diseases and programs are identified as teaching material through e-learning resources on the knowledge base on Infectious diseases by many Universities in world, Active educator on Infection control matters educating Doctors Nurses paramedical professional and enjoy the support of millions of viewers who use those to train and practice to control Infectious Diseases. Recently appointed as as consultant and Clinical Microbiologist and chairperson of Institutional Ethical committees of Medical, Dental Yoga and Nursing schools in India, At present working with a Mission to bring in basic principles with educative materials to control and prevention of Infectious diseases knowledge base to many developing and developed countries with a e-knowledge resources